Summary by Futu AI
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on May 29, 2024. The transaction was executed at a price of $445.56 per share, resulting in a total sale value of approximately $1,015,876.80. Following the sale, Bozic's direct holdings in the company amount to 34,659 shares. The sale took place through an open market transaction, as reported in the company's latest filing.